Impaired parkin-mediated mitochondrial targeting to autophagosomes differentially contributes to tissue pathology in lysosomal storage diseases.
Dysfunctional mitochondria are a well-known disease hallmark. The accumulation of aberrant mitochondria can alter cell homeostasis, thus resulting in tissue degeneration. Lysosomal storage disorders (LSDs) are a group of inherited diseases characterized by the buildup of undegraded material inside the lysosomes that leads to autophagic-lysosomal dysfunction. In LSDs, autophagic stress has been associated to mitochondrial accumulation and dysfunction. However, the mechanisms underlying mitochondrial aberrations and how these are involved in tissue pathogenesis remain largely unexplored. In normal conditions, mitochondrial clearance occurs by mitophagy, a selective form of autophagy, which relies on a parkin-mediated mitochondrial priming and subsequent sequestration by autophagosomes. Here, we performed a detailed analysis of key steps of mitophagy in a mouse model of multiple sulfatase deficiency (MSD), a severe type of LSD characterized by both neurological and systemic involvement. We demonstrated that in MSD liver reduced parkin levels resulted in inefficient mitochondrial priming, thus contributing to the accumulation of giant mitochondria that are located outside autophagic vesicles ultimately leading to cytochrome c release and apoptotic cell death. Morphological and functional changes were also observed in mitochondria from MSD brain but these were not directly associated with neuronal cell loss, suggesting a secondary contribution of mitochondria to neurodegeneration. Together, these data shed new light on the mechanisms underlying mitochondrial dysfunction in LSDs and on their tissue-specific differential contribution to the pathogenesis of this group of metabolic disorders.
Telethon Institute of Genetics and Medicine, Naples 80131, Italy.
Raquel
R
de Pablo-Latorre
Assunta
A
Saide
Elena V
EV
Polishhuck
Edoardo
E
Nusco
Alessandro
A
Fraldi
Andrea
A
Ballabio
D000818:Animals; D017209:Apoptosis; D001343:Autophagy; D001921:Brain / Q000473:pathology; D045304:Cytochromes c / Q000378:metabolism; D004195:Disease Models, Animal; D008099:Liver / Q000473:pathology; D051379:Mice; D008928:Mitochondria / Q000378:metabolism / Q000648:ultrastructure; D008930:Mitochondria, Liver / Q000378:metabolism* / Q000648:ultrastructure*; D052517:Multiple Sulfatase Deficiency Disease / Q000235:genetics / Q000378:metabolism* / Q000473:pathology*; D010588:Phagosomes / Q000378:metabolism*; D044767:Ubiquitin-Protein Ligases / Q000378:metabolism*; D054875:Ubiquitination
D045304:Cytochromes c; D044767:Ubiquitin-Protein Ligases; C111567:parkin protein